Skip to main content
Advertisement
  • Neurology.org
  • Journals
    • Neurology
    • Clinical Practice
    • Genetics
    • Neuroimmunology & Neuroinflammation
  • Specialty Sites
    • COVID-19
    • Practice Current
    • Practice Buzz
    • Without Borders
    • Equity, Diversity and Inclusion
    • Innovations in Care Delivery
  • Collections
    • Topics A-Z
    • Residents & Fellows
    • Infographics
    • Patient Pages
    • Null Hypothesis
    • Translations
  • Podcast
  • CME
  • About
    • About the Journals
    • Contact Us
    • Editorial Board
  • Authors
    • Submit a Manuscript
    • Author Center

Advanced Search

Main menu

  • Neurology.org
  • Journals
    • Neurology
    • Clinical Practice
    • Genetics
    • Neuroimmunology & Neuroinflammation
  • Specialty Sites
    • COVID-19
    • Practice Current
    • Practice Buzz
    • Without Borders
    • Equity, Diversity and Inclusion
    • Innovations in Care Delivery
  • Collections
    • Topics A-Z
    • Residents & Fellows
    • Infographics
    • Patient Pages
    • Null Hypothesis
    • Translations
  • Podcast
  • CME
  • About
    • About the Journals
    • Contact Us
    • Editorial Board
  • Authors
    • Submit a Manuscript
    • Author Center
  • Home
  • Latest Articles
  • Current Issue
  • Past Issues
  • Residents & Fellows

User menu

  • Subscribe
  • My Alerts
  • Log in

Search

  • Advanced search
Neurology
Home
The most widely read and highly cited peer-reviewed neurology journal
  • Subscribe
  • My Alerts
  • Log in
Site Logo
  • Home
  • Latest Articles
  • Current Issue
  • Past Issues
  • Residents & Fellows

Share

April 06, 2015; 84 (14 Supplement) April 24, 2015

Effect of MD1003 (High Doses of Biotin) in Progressive Multiple Sclerosis: Results of a Pivotal Phase III Randomized Double Blind Placebo Controlled Study (PL2.002)

Ayman Tourbah, Christine Lebrun Frenay, Gilles Edan, Michel Clanet, Caroline Papeix, Sandra Vukusic, Jerome De Seze, Marc Debouverie, Olivier Gout, Pierre Clavelou, Gilles Defer, David Laplaud, Thibault Moreau, Pierre Labauge, Bruno Brochet, Frederic Sedel, Jean Pelletier
First published April 8, 2015,
Ayman Tourbah
6Department of Neurology, CHU de Reims Reims France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Christine Lebrun Frenay
10Hopital Pasteur Nice France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gilles Edan
4Neurology CHU de Rennes Rennes France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michel Clanet
17Service de Neurologie Toulouse France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Caroline Papeix
16Pitie Salpetriere Paris France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sandra Vukusic
12Hospital Neuro P Wertheimer Lyon France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jerome De Seze
5Neurology CHU de Strasbourg Strasbourg France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Marc Debouverie
11Hospital Central Nancy France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Olivier Gout
7Fondation De Rothschild Paris France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Pierre Clavelou
9Hopital Gabriel Montpied Clermont Ferrand France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gilles Defer
8Hopital Cote De Nacre Caen France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
David Laplaud
3CHU de Nantes Nantes France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Thibault Moreau
1CHU de Dijon Dijon France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Pierre Labauge
2CHU de Montpellier Montpellier France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Bruno Brochet
13Hospital Pellegrin, Neurology Dept Bordeaux France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Frederic Sedel
15Medday Pharmaceuticals Paris France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jean Pelletier
14Hospital Timone Adultes Marseille France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Citation
Effect of MD1003 (High Doses of Biotin) in Progressive Multiple Sclerosis: Results of a Pivotal Phase III Randomized Double Blind Placebo Controlled Study (PL2.002)
Ayman Tourbah, Christine Lebrun Frenay, Gilles Edan, Michel Clanet, Caroline Papeix, Sandra Vukusic, Jerome De Seze, Marc Debouverie, Olivier Gout, Pierre Clavelou, Gilles Defer, David Laplaud, Thibault Moreau, Pierre Labauge, Bruno Brochet, Frederic Sedel, Jean Pelletier
Neurology Apr 2015, 84 (14 Supplement) PL2.002;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Permissions

Make Comment

See Comments

Downloads
0

Share

  • Article
  • Info & Disclosures
Loading

Article Information

vol. 84 no. 14 Supplement PL2.002

Published By: 
Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology
Print ISSN: 
0028-3878
Online ISSN: 
1526-632X
History: 
  • First Published April 8, 2015.

Copyright & Usage: 
Copyright © 2015 by AAN Enterprises, Inc.

Author Disclosures

    1. Ayman Tourbah6,
    2. Christine Lebrun Frenay10,
    3. Gilles Edan4,
    4. Michel Clanet17,
    5. Caroline Papeix16,
    6. Sandra Vukusic12,
    7. Jerome De Seze5,
    8. Marc Debouverie11,
    9. Olivier Gout7,
    10. Pierre Clavelou9,
    11. Gilles Defer8,
    12. David Laplaud3,
    13. Thibault Moreau1,
    14. Pierre Labauge2,
    15. Bruno Brochet13,
    16. Frederic Sedel15 and
    17. Jean Pelletier14
  1. Ayman Tourbah6,
  2. Christine Lebrun Frenay10,
  3. Gilles Edan4,
  4. Michel Clanet17,
  5. Caroline Papeix16,
  6. Sandra Vukusic12,
  7. Jerome De Seze5,
  8. Marc Debouverie11,
  9. Olivier Gout7,
  10. Pierre Clavelou9,
  11. Gilles Defer8,
  12. David Laplaud3,
  13. Thibault Moreau1,
  14. Pierre Labauge2,
  15. Bruno Brochet13,
  16. Frederic Sedel15 and
  17. Jean Pelletier14
  1. 1CHU de Dijon Dijon France
  2. 2CHU de Montpellier Montpellier France
  3. 3CHU de Nantes Nantes France
  4. 4Neurology CHU de Rennes Rennes France
  5. 5Neurology CHU de Strasbourg Strasbourg France
  6. 6Department of Neurology, CHU de Reims Reims France
  7. 7Fondation De Rothschild Paris France
  8. 8Hopital Cote De Nacre Caen France
  9. 9Hopital Gabriel Montpied Clermont Ferrand France
  10. 10Hopital Pasteur Nice France
  11. 11Hospital Central Nancy France
  12. 12Hospital Neuro P Wertheimer Lyon France
  13. 13Hospital Pellegrin, Neurology Dept Bordeaux France
  14. 14Hospital Timone Adultes Marseille France
  15. 15Medday Pharmaceuticals Paris France
  16. 16Pitie Salpetriere Paris France
  17. 17Service de Neurologie Toulouse France

Article usage

Article usage: April 2015 to January 2021

AbstractFullPdfSource
Apr 201520900Highwire
May 201541100Highwire
Jun 201533500Highwire
Jul 201524800Highwire
Aug 201523500Highwire
Sep 201520700Highwire
Oct 201519000Highwire
Nov 201520700Highwire
Dec 201515900Highwire
Jan 201615300Highwire
Feb 201620500Highwire
Mar 201620800Highwire
Apr 201617300Highwire
May 201618800Highwire
Jun 201622500Highwire
Jul 201616400Highwire
Aug 201621300Highwire
Sep 201624600Highwire
Oct 201616700Highwire
Nov 201618600Highwire
Dec 201613100Highwire
Jan 201730100Highwire
Feb 201711600Highwire
Mar 201715300Highwire
Apr 201717200Highwire
May 201718100Highwire
Jun 201717100Highwire
Jul 201712600Highwire
Aug 201748100Highwire
Sep 201714800Highwire
Oct 201726100Highwire
Nov 201718600Highwire
Dec 201712500Highwire
Jan 201814700Highwire
Feb 201811500Highwire
Mar 201810700Highwire
Apr 20188600Highwire
May 201812700Highwire
Jun 201811800Highwire
Jul 20189800Highwire
Aug 20187300Highwire
Sep 20189800Highwire
Oct 20188300Highwire
Nov 201825500Highwire
Dec 20189200Highwire
Jan 20199300Highwire
Feb 20199100Highwire
Mar 20199400Highwire
Apr 20197300Highwire
May 201911700Highwire
Jun 20198500Highwire
Jul 20199600Highwire
Aug 20198500Highwire
Sep 20199500Highwire
Oct 201912000Highwire
Nov 201913600Highwire
Dec 201914100Highwire
Jan 202016300Highwire
Feb 20209200Highwire
Mar 20205800Highwire
Apr 20203500Highwire
May 20207900Highwire
Jun 20203000Highwire
Jul 20205100Highwire
Aug 20203700Highwire
Sep 20203700Highwire
Oct 20205400Highwire
Nov 20207000Highwire
Dec 20202900Highwire
Jan 20214000Highwire

Disputes & Debates: Rapid online correspondence

No comments have been published for this article.
Comment

NOTE: All authors' disclosures must be entered and current in our database before comments can be posted. Enter and update disclosures at http://submit.neurology.org. Exception: replies to comments concerning an article you originally authored do not require updated disclosures.

  • Stay timely. Submit only on articles published within the last 8 weeks.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • 200 words maximum.
  • 5 references maximum. Reference 1 must be the article on which you are commenting.
  • 5 authors maximum. Exception: replies can include all original authors of the article.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Disputes & Debates Submission Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
  • Article
  • Info & Disclosures
Advertisement

Related Articles

  • No related articles found.

Alert Me

  • Alert me when eletters are published
Neurology: 96 (9)

Articles

  • Ahead of Print
  • Current Issue
  • Past Issues
  • Popular Articles
  • Translations

About

  • About the Journals
  • Ethics Policies
  • Editors & Editorial Board
  • Contact Us
  • Advertise

Submit

  • Author Center
  • Submit a Manuscript
  • Information for Reviewers
  • AAN Guidelines
  • Permissions

Subscribers

  • Subscribe
  • Activate a Subscription
  • Sign up for eAlerts
  • RSS Feed
Site Logo
  • Visit neurology Template on Facebook
  • Follow neurology Template on Twitter
  • Visit Neurology on YouTube
  • Neurology
  • Neurology: Clinical Practice
  • Neurology: Genetics
  • Neurology: Neuroimmunology & Neuroinflammation
  • AAN.com
  • AANnews
  • Continuum
  • Brain & Life
  • Neurology Today

Wolters Kluwer Logo

Neurology | Print ISSN:0028-3878
Online ISSN:1526-632X

© 2021 American Academy of Neurology

  • Privacy Policy
  • Feedback
  • Advertise